查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1518263

2024 年无细胞 DNA (cfDNA) 测试全球市场报告

Cell Free DNA (cfDNA) Testing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

无细胞 DNA (cfDNA) 测试市场规模预计在未来几年将呈指数级增长。 2028年，将以23.9%的复合年增长率成长至206.3亿美元。预测期内的成长动力是向个人化医疗的转变、医疗保健基础设施的改善、人口老化和癌症发生率的上升。此外，精准医学的日益普及、对液态切片技术的认识和接受度不断提高，以及对 cfDNA 研究的投资和资金筹措的增加，也促进了这一增长。这段时期的主要趋势包括液态切片技术的采用、下一代定序 (NGS) 技术的进步、人工智慧和机器学习在 cfDNA 测试中的整合、照护现场cfDNA 测试的发展以及资料的改进其中包括引入云端基础的平台。

癌症盛行率的不断上升预计将推动未来无细胞 DNA (cfDNA) 检测市场的成长。癌症包括一组复杂的疾病，其特征是体内异常细胞的生长和扩散。这些细胞可以侵入并损害正常组织，如果不及时治疗，会造成重大风险。癌症发生率的增加是由于人口老化、生活方式的改变、环境影响以及检测和诊断方法的进步等因素造成的。 cfDNA 检测可以在早期（通常在症状出现之前）检测到与癌症相关的基因突变。这种早期检测可以及时干预，并透过在早期阶段识别癌症来改善患者的治疗结果和存活率。例如，2024 年 2 月，世界卫生组织 (WHO) 预测，到 2050 年，新增癌症病例数将超过 3,500 万例，比 2022 年估计的 2,000 万例增加 %。因此，癌症盛行率的增加正在推动无细胞 DNA (cfDNA) 检测市场的成长。

无细胞 DNA (cfDNA) 测试市场的主要参与者正在优先开拓创新技术，例如液态切片测试，这些技术可以提高检测与癌症相关的突变和基因变化的灵敏度、特异性和效率。液态切片测试是一种诊断程序，使肿瘤学家能够评估癌细胞释放的循环游离 DNA，从而促进个人化的标靶治疗策略。例如，2023年5月，美国生命科学公司Laboratory Corporation of America Holdings (Labcorp)宣布推出专为进行性或转移性固体癌患者量身定制的新型液态切片测试Labcorp Plasma。该测试透过标准抽血评估从癌细胞中提取的循环游离 DNA (cfDNA)，具有微创性，可快速提供结果。此检验可辨识多种常见癌症的临床可操作生物标记物，包括非小细胞肺癌、大肠直肠癌、乳癌、食道癌、胃食道交界处癌、胃癌和黑色素瘤。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球游离 DNA (cfDNA) 检测市场驱动因素和阻碍因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球游离 DNA (cfDNA) 检测市场规模、表现与成长
  • 全球游离 DNA (cfDNA) 检测市场规模与成长预测，2023-2028、2033F

第六章 市场细分

  • 全球游离 DNA (cfDNA) 测试市场：按产品分類的绩效和预测，2018-2023、2023-2028F、2033F
  • 来自捐赠者的游离 DNA
  • 循环无细胞肿瘤DNA
  • 胎儿游离DNA
  • 全球游离 DNA (cfDNA) 测试市场：按平台分類的绩效和预测，2018-2023、2023-2028F、2033F
  • 次世代定序（NGS）
  • rPCR 和多重 PCR
  • qPCR 和 dPCR
  • 其他平台
  • 全球游离 DNA (cfDNA) 测试市场：按应用分類的表现和预测，2018-2023、2023-2028F、2033F
  • 肿瘤学
  • 非侵入性产前检测（NIPT）
  • 妇科
  • 移植
  • 其他用途

第 7 章 区域/国家分析

  • 全球游离 DNA (cfDNA) 测试市场，按地区、绩效和预测，2018-2023、2023-2028F、2033F
  • 全球游离 DNA (cfDNA) 测试市场，按国家、绩效和预测，2018-2023、2023-2028F、2033F

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 游离DNA（cfDNA）检测市场的竞争格局
  • 无细胞 DNA (cfDNA) 测试市场公司概况
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Agilent Technologies Inc.

第三十一章 其他重大及创新企业

  • Illumina Inc.
  • Qiagen NV
  • Exact Sciences Corporation
  • Bio-Techne Corporation
  • Natera Inc.
  • Myriad Genetics Inc.
  • NeoGenomics Laboratories Inc.
  • Invitae Corporation
  • Foundation Medicine Inc.
  • Guardant Health Inc.
  • Integrated DNA Technologies Inc.
  • Caris Life Sciences Inc.
  • Twist Bioscience Corporation
  • Adaptive Biotechnologies Corporation
  • Biodesix Inc.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r18308

Cell-free DNA (cfDNA) testing is a non-invasive diagnostic technique that examines DNA fragments freely circulating in the bloodstream. This testing method is integral to liquid biopsy procedures, enabling the detection and analysis of genetic mutations and alterations without resorting to traditional tissue biopsies.

The primary products within the cell-free DNA (cfDNA) testing market include donor-derived cell-free DNA, circulating cell-free tumor DNA, and cell-free fetal DNA. Donor-derived cell-free DNA originates from transplanted donor organs or tissues and can be found in the recipient's bloodstream. Various platforms are utilized for cfDNA testing, such as next-generation sequencing (NGS), real-time PCR (rPCR) and multiplex PCR, quantitative PCR (qPCR) and digital PCR (dPCR), among others. These platforms are applied across various domains including oncology, non-invasive prenatal testing (NIPT), gynecology, transplantation, and other medical conditions.

The cell-free DNA (cfDNA) testing market research report is one of a series of new reports from The Business Research Company that provides cell-free DNA (cfDNA) testing market statistics, including cell-free DNA (cfDNA) testing industry global market size, regional shares, competitors with a cell-free DNA (cfDNA) testing market share, detailed cell-free DNA (cfDNA) testing market segments, market trends, and opportunities, and any further data you may need to thrive in the cell-free DNA (cfDNA) testing industry. This cell-free DNA (cfDNA) testing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell free DNA (cfDNA) testing market size has grown exponentially in recent years. It will grow from $7.07 billion in 2023 to $8.74 billion in 2024 at a compound annual growth rate (CAGR) of 23.6%. The growth during the historic period can be attributed to several factors, including the increased adoption of cfDNA testing in prenatal care, a growing utilization of cfDNA analysis, heightened interest in cfDNA research across various medical fields, and an increase in gaining approvals from regulatory bodies.

The cell free DNA (cfDNA) testing market size is expected to see exponential growth in the next few years. It will grow to $20.63 billion in 2028 at a compound annual growth rate (CAGR) of 23.9%. In the forecast period, growth can be attributed to a shift towards personalized medicine, improvements in healthcare infrastructure, an aging population, and the increasing incidence of cancer. Additionally, the increasing adoption of precision medicine, growing awareness and acceptance of liquid biopsy techniques, and rising investment and funding in cfDNA research are contributing to this growth. Major trends during this period include the adoption of liquid biopsy technologies, advancements in Next-Generation Sequencing (NGS) technology, integration of AI and machine learning in cfDNA testing, development of point-of-care cfDNA tests, and the implementation of cloud-based platforms for data storage and analysis.

The increasing prevalence of cancer is expected to drive the growth of the cell-free DNA (cfDNA) testing market in the future. Cancer encompasses a complex group of diseases characterized by abnormal cell growth and spread in the body. These cells can invade and damage normal tissue, posing significant risks if left unchecked. The rise in cancer prevalence is attributed to factors such as aging populations, lifestyle changes, environmental influences, and advancements in detection and diagnostic methods. cfDNA testing detects genetic mutations linked to cancer at early stages, often before symptoms manifest. This early detection enables timely interventions, enhancing patient outcomes and survival rates by identifying cancer in its initial phases. For example, in February 2024, the World Health Organization (WHO) projected over 35 million new cancer cases by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Hence, the increasing prevalence of cancer is fueling the growth of the cell-free DNA (cfDNA) testing market.

Key players in the cell-free DNA (cfDNA) testing market prioritize the development of innovative technologies, such as liquid biopsy tests that offer heightened sensitivity, specificity, and efficiency in detecting cancer-related mutations and genetic changes. Liquid biopsy tests involve diagnostic procedures enabling oncologists to assess circulating cell-free DNA released by tumor cells, facilitating personalized and targeted therapy strategies. For instance, in May 2023, Laboratory Corporation of America Holdings (Labcorp), a US-based life sciences company, introduced Labcorp Plasma Focus, a new liquid biopsy test tailored for patients with advanced or metastatic solid tumors. This test evaluates circulating cell-free DNA (cfDNA) from tumor cells through a standard blood draw, ensuring minimal invasiveness and rapid results. It enhances access to precision oncology by identifying clinically actionable biomarkers across various common cancers such as non-small cell lung, colorectal, breast, esophageal, gastroesophageal junction, gastric cancers, and melanoma.

In February 2022, Laboratory Corporation of America Holdings (LabCorp), a US-based clinical healthcare company, acquired Personal Genome Diagnostics Inc. for an undisclosed sum. This acquisition positions LabCorp to advance its existing liquid biopsy capabilities and broaden its array of state-of-the-art next-generation sequencing (NGS)-based genomic profiling tools for cancer, positioning it at the forefront of improving patient outcomes. Personal Genome Diagnostics Inc. specializes in precision oncology diagnostics, including cell-free DNA testing technology.

Major companies operating in the cell free DNA (CFDNA) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Bio-Techne Corporation, Natera Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Invitae Corporation, Foundation Medicine Inc., Guardant Health Inc., Integrated DNA Technologies Inc., Caris Life Sciences Inc., Twist Bioscience Corporation, Adaptive Biotechnologies Corporation, Biodesix Inc., Biocept Inc., Personal Genome Diagnostics Inc., Agena Bioscience Inc., Menarini Silicon Biosystems Inc., Circulogene Theranostics LLC

North America was the largest region in the cell-free DNA (CFDNA) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell free DNA (CFDNA)) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell free DNA (CFDNA) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell-free DNA (cfDNA) testing market consists of revenue entities earned by providing services such as liquid biopsy for cancer detection and monitoring, transplant rejection monitoring, and non-invasive prenatal testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell-free DNA (cfDNA) testing market also includes sales of products such as digital PCR systems, automated nucleic acid extraction systems, real-time PCR instruments, and library preparation systems for NGS. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Free DNA (cfDNA) Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell free dna (cfdna) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell free dna (cfdna) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell free dna (cfdna) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Donor-Derived Cell-Free DNA; Circulating Cell-Free Tumor DNA; Cell-Free Fetal DNA
  • 2) By Platforms: Next Generation Sequencing (NGS); rPCR And Multiplexed PCR; qPCR And dPCR; Other platforms
  • 3) By Application: Oncology; Non-Invasive Prenatal Test (NIPT); Gynecology; Transplantation; Other Applications
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Agilent Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell-Free DNA (cfDNA) Testing Market Characteristics

3. Cell-Free DNA (cfDNA) Testing Market Trends And Strategies

4. Cell-Free DNA (cfDNA) Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cell-Free DNA (cfDNA) Testing Market Size and Growth

  • 5.1. Global Cell-Free DNA (cfDNA) Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cell-Free DNA (cfDNA) Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cell-Free DNA (cfDNA) Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell-Free DNA (cfDNA) Testing Market Segmentation

  • 6.1. Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Donor-Derived Cell-Free DNA
  • Circulating Cell-Free Tumor DNA
  • Cell-Free Fetal DNA
  • 6.2. Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Next Generation Sequencing (NGS)
  • rPCR And Multiplexed PCR
  • qPCR And dPCR
  • Other platforms
  • 6.3. Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Non-Invasive Prenatal Test (NIPT)
  • Gynecology
  • Transplantation
  • Other Applications

7. Cell-Free DNA (cfDNA) Testing Market Regional And Country Analysis

  • 7.1. Global Cell-Free DNA (cfDNA) Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cell-Free DNA (cfDNA) Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market

  • 8.1. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell-Free DNA (cfDNA) Testing Market

  • 9.1. China Cell-Free DNA (cfDNA) Testing Market Overview
  • 9.2. China Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell-Free DNA (cfDNA) Testing Market

  • 10.1. India Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell-Free DNA (cfDNA) Testing Market

  • 11.1. Japan Cell-Free DNA (cfDNA) Testing Market Overview
  • 11.2. Japan Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell-Free DNA (cfDNA) Testing Market

  • 12.1. Australia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell-Free DNA (cfDNA) Testing Market

  • 13.1. Indonesia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell-Free DNA (cfDNA) Testing Market

  • 14.1. South Korea Cell-Free DNA (cfDNA) Testing Market Overview
  • 14.2. South Korea Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell-Free DNA (cfDNA) Testing Market

  • 15.1. Western Europe Cell-Free DNA (cfDNA) Testing Market Overview
  • 15.2. Western Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell-Free DNA (cfDNA) Testing Market

  • 16.1. UK Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell-Free DNA (cfDNA) Testing Market

  • 17.1. Germany Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell-Free DNA (cfDNA) Testing Market

  • 18.1. France Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell-Free DNA (cfDNA) Testing Market

  • 19.1. Italy Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell-Free DNA (cfDNA) Testing Market

  • 20.1. Spain Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell-Free DNA (cfDNA) Testing Market

  • 21.1. Eastern Europe Cell-Free DNA (cfDNA) Testing Market Overview
  • 21.2. Eastern Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell-Free DNA (cfDNA) Testing Market

  • 22.1. Russia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell-Free DNA (cfDNA) Testing Market

  • 23.1. North America Cell-Free DNA (cfDNA) Testing Market Overview
  • 23.2. North America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell-Free DNA (cfDNA) Testing Market

  • 24.1. USA Cell-Free DNA (cfDNA) Testing Market Overview
  • 24.2. USA Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell-Free DNA (cfDNA) Testing Market

  • 25.1. Canada Cell-Free DNA (cfDNA) Testing Market Overview
  • 25.2. Canada Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell-Free DNA (cfDNA) Testing Market

  • 26.1. South America Cell-Free DNA (cfDNA) Testing Market Overview
  • 26.2. South America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell-Free DNA (cfDNA) Testing Market

  • 27.1. Brazil Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell-Free DNA (cfDNA) Testing Market

  • 28.1. Middle East Cell-Free DNA (cfDNA) Testing Market Overview
  • 28.2. Middle East Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell-Free DNA (cfDNA) Testing Market

  • 29.1. Africa Cell-Free DNA (cfDNA) Testing Market Overview
  • 29.2. Africa Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell-Free DNA (cfDNA) Testing Market Competitive Landscape And Company Profiles

  • 30.1. Cell-Free DNA (cfDNA) Testing Market Competitive Landscape
  • 30.2. Cell-Free DNA (cfDNA) Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Laboratory Corporation of America Holdings
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Quest Diagnostics Incorporated
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Agilent Technologies Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cell-Free DNA (cfDNA) Testing Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Qiagen N.V.
  • 31.3. Exact Sciences Corporation
  • 31.4. Bio-Techne Corporation
  • 31.5. Natera Inc.
  • 31.6. Myriad Genetics Inc.
  • 31.7. NeoGenomics Laboratories Inc.
  • 31.8. Invitae Corporation
  • 31.9. Foundation Medicine Inc.
  • 31.10. Guardant Health Inc.
  • 31.11. Integrated DNA Technologies Inc.
  • 31.12. Caris Life Sciences Inc.
  • 31.13. Twist Bioscience Corporation
  • 31.14. Adaptive Biotechnologies Corporation
  • 31.15. Biodesix Inc.

32. Global Cell-Free DNA (cfDNA) Testing Market Competitive Benchmarking

33. Global Cell-Free DNA (cfDNA) Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cell-Free DNA (cfDNA) Testing Market

35. Cell-Free DNA (cfDNA) Testing Market Future Outlook and Potential Analysis

  • 35.1 Cell-Free DNA (cfDNA) Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cell-Free DNA (cfDNA) Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cell-Free DNA (cfDNA) Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer